Fisher Added to BCW Index | GenomeWeb

This week, Fisher Scientific becomes the latest company to join the BCW Index. The firm, which completed its purchase of high-content screening firm Cellomics a couple of weeks ago, has been a competitor to several firms in the Index over the past couple of years through its RNAi and protein assay kits and reagents, and now will compete against others with its cell screening operations (see related article).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.